chrisvoncsefalvay/vaers-outcomes huggingface dataset:
multiple subsegmental pulmonary emboli; blood clot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PULMONARY EMBOLISM (multiple subsegmental pulmonary emboli) and THROMBOSIS (blood clot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PULMONARY EMBOLISM (multiple subsegmental pulmonary emboli) (seriousness criterion medically significant) and THROMBOSIS (blood clot) (seriousness criterion medically significant). At the time of the report, PULMONARY EMBOLISM (multiple subsegmental pulmonary emboli) and THROMBOSIS (blood clot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were provided.  Very limited information regarding this event/s has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Cough; Spiked proteins; Body aches; A low grade fever; This spontaneous case was reported by an other health care professional and describes the occurrence of COUGH (Cough), SUSPECTED COVID-19 (Spiked proteins), MYALGIA (Body aches) and PYREXIA (A low grade fever) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concomitant products included NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), CITALOPRAM HYDROBROMIDE (CELEXA [CITALOPRAM HYDROBROMIDE]), WARFARIN SODIUM (COUMADIN), OMEPRAZOLE and LEVOTHYROXINE for an unknown indication.    On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (Cough), SUSPECTED COVID-19 (Spiked proteins), MYALGIA (Body aches) and PYREXIA (A low grade fever). The patient was treated with ACYCLOVIR [ACICLOVIR] for Shingles, at an unspecified dose and frequency. At the time of the report, COUGH (Cough) and SUSPECTED COVID-19 (Spiked proteins) outcome was unknown and MYALGIA (Body aches) and PYREXIA (A low grade fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-301941 (Patient Link).
Unsure if received 1 or 2 doses, unsure if had 2nd dose; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient did not receive the 2nd dose of Shingrix as per the vaccination schedule, which led to incomplete course of vaccination. The patient was unsure if he ever had his second dose of Shingrix. The reporter asked if she could just send the patient for a 2nd dose. The reporter consented to follow up. However, it was unable to verify consent to follow-up because Healthcare professional was unable to be reached. Note: The case was kept valid conservatively.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with ZOSTAVAX. On an unknown date, the patient experienced redness and swelling not just at injection site but it traveled up the whole area above the elbow. The outcome of erythema, peripheral swelling, injection site swelling and injection site erythema is unknown. The reporter refused to provide any additional information and did not provide permission to contact. Additional information is not expected.
Redness, swelling, hot at left deltoid with a knot, 2 days post vax. Pt was prescribed Keflex.
sporadic episodes of dizziness; tired; headache; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd January 2022, the patient received the 2nd dose of Shingrix (intramuscular). In January 2022, less than a week after receiving Shingrix, the patient experienced tiredness, headache and dizziness. On an unknown date, the outcome of the tiredness and headache were recovered/resolved and the outcome of the dizziness was not recovered/not resolved.   It was unknown if the reporter considered the tiredness, headache and dizziness to be related to Shingrix.  Additional details were provided as follows: The patient self reported this case. The patient received dose of Shingrix vaccine and for two days after the vaccination, she felt tired and had a headache. About three days after vaccination she experienced sporadic episodes of dizziness. The dizziness continued to come and go. Sometimes the dizziness occurred during yoga, sometimes when she lied down in bed, and sometimes when she sat up. The patient had an appointment with her physician next week.  The reporter consents to follow up with physician but can't remember the spelling of her last name or contact information.
I was exposed to a respiratory virus sometime after the vaccine. I tested for COVID-19 but was negative, so it was a different virus. I had a really sore throat for 3 days and a cough, muscles aches, and a slight fever. Then it seemed to get better but then it hit me again harder as if there was another virus as well. I do have asthma and it was acting up, and I haven't had a asthma attack in about 5 years previously to this. I am reporting because in the back of my mind, did the vaccine make and other symptoms or viruses worse? I feel like it did.
dizzy, lightheaded. Extreme exhaustion. fever over 100. Dry heaves for a couple of hours too. lasted for 3 days. sore site for 5 days. couldnt do much of anything for the first two days. fever gone 3rd day. energy level improved some by 4th day.
This spontaneous report as received from a doctor of pharmacy refers to a currently 76 years old male patient. The patient was vaccinated with a dose of lot # (670986/0730AA; 17-AUG-2012) ZOSTAVAX on 06-DEC-2011 (dose and route not reported). No other co-suspects and no concomitant medications were reported. The pharmacist reported that the patient has had two cases of shingles following vaccination with ZOSTAVAX. The date of the first case of shingles was unspecified and the date of resolution was also unspecified. At the time of the report the patient currently had the second case of shingles (Start date unspecified). The patient sought medical attention by contacting the pharmacist. No treatment information was reported. At the time of the report the outcome of shingles was reported as not recovered. The relatedness shingles was not reported for ZOSTAVAX. Additional information has been requested.
An expired dose of MENACTRA was given to a patient the dose expired on X/XX/2012 and dose was given on X/XX/2012 (next day). We have removed the vaccine from the fridge and the patient will be revaccinated.
1st Moderna vaccine received on:  6.3.21 -- symptoms of soreness and fatigue lasted a few days. 2nd Moderna vaccine received on: 7.9.21 -- severe adverse reaction which persists to this day includes:  Extreme fatigue, hair loss and brain fog.  Was attending college and received straight "A" grades until receiving Moderna vaccine - after which I was unable to complete my college courses and had to forfeit my college scholarship.  Extreme fatigue, hair loss, and brain fog persist to this day.  Transported via ambulance to hospital emergency room as my physician feared I may have had a stroke.
PAIN SWELLING, REDNESS AT INJECTION SITE. BODY ACHES. 1/15 HEADACHE, BODY ACHES, JOINT PAIN,FATIGUE, ITCHING RESOLVED IN 7 DAYS Narrative:  Other Relevant History:
tiny red spots on my skin too/like pin pricks with bits of blood; nausea; Continous headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (tiny red spots on my skin too/like pin pricks with bits of blood), NAUSEA (nausea) and HEADACHE (Continous headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (tiny red spots on my skin too/like pin pricks with bits of blood), NAUSEA (nausea) and HEADACHE (Continous headache). At the time of the report, RASH MACULAR (tiny red spots on my skin too/like pin pricks with bits of blood), NAUSEA (nausea) and HEADACHE (Continous headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
About 21 hours after getting the vaccine I felt a numbing/tingling all over my face and top of my scalp. It felt like after going to the dentist and the numbing is wearing off. I had shingles years ago, and it also reminded me of that feeling,  but not painful. This tingling lasted about an hour and didn't return.
Within a few minutes experienced tightness in my chest, difficulty swallowing and catching my breath and then feeling like my throat and tongue were swollen and a metallic taste in my mouth that lingered for over an hour. Elevated blood pressure, but oxygen levels were ok. Was monitored for 30 minutes until blood pressure returned normal and i could swallow. Returned home and took 4 benadryl over the course of 4 hours, throat, mouth and tongue remained swollen through Thursday, 19 AUG - PCP ordered prednisone which was taken starting Wednesday. Upon removing bandaid from injection site - there were hives and irritation, arm was swollen and painful for over 4 days.
Rec'd vaccination on Monday. Returned Wed with LUE erythema, pain, and swelling from axilla to elbow. Rapidly enlarging. Admitted for IV Abx septic w/u. Monitored for possible abscess, compartment syndrome. Given IV BENADRYL no pain medications. Resolved after 2 days inpatient. All cx negative.
After 24 hours I began to feel a slight headache and mild body aches. It felt exactly like the day I first noticed my covid symptoms back in November. However, it continued to progress rapidly and I was unable to enter a nursing home because my temp had gone up to 101. I ended up very achy and confined to bed for the next 24 hours. While not as lengthy as my covid infection, the symptoms were much worse.
Within a minute of having COVID19 vaccine, I experienced difficulty breathing, headache, chest pain, itchy skin on face and neck, and redness in same locations. Was given Benadryl by one of two doctors at the site.  Was sent to a local Medical Center for epi pen but that night (was not driving thankfully) had three asthma attacks, had breathing treatment at 2:30am after experiencing a major asthma attack, difficulty sleeping after that for remainder of morning, and chest pain worsened.  Since I was not allowed to drive, I could not go into hospital for medical assistance.  Took Benadryl again because I had never used an epi pen before so chose not to use it in case I worsened and due to living myself.  one of the doctor at vaccination site, did not recommend a second dose.  Cardiologist had recommended a heart event monitor which documented Tachycardia with PVCs during the month of March 2021.  Record from Dr. at the Medical Center-Cardiologist for 3/31/2021 shows documentation regarding from heart event monitor.
This spontaneous report as received from a registered nurse refers to a female patient of unknown age. On approximately April 2009, "five years ago", the patient was vaccinated with the first 0.5 ml dose of GARDASIL (lot # not reported) IM and on 07-APR-2014, the patient received her second 0.5 ml dose of GARDASIL (lot # not reported) IM. No adverse effect was reported. Additional information has been requested.
Nurse pulled wrong immunization other nurse drew up and gave wrong immunization. Provider notified and explained and discussed with mother. Mother states understanding and ok. Correct immunization given. Mother informed to call clinic with any questions or problems.
Client's guardian gave inaccurate information regarding  client's name and date of birth (given as name and date of birth as 3/10/2011). Client is only 10 years old and is not eligible for Covid vaccination. No adverse event is known to have occurred.
Narrative: COVID infection following COVID vaccine series 03/24, Pfizer, dose#1 04/14, Pfizer, dose #2 09/05 pt cc: myalgias, rhinorrhea, cough, fatigue, exposure: Cruise ship 09/10 COVID swab, result: detected 09/10 pt admit to ED cc: weakness/cough/body aches x 5 days dx: Coronavirus LOS: 1 09/10 SARS-COV-2 Variant Sequencing result: pending 09/10 CXR impression: No active disease.
Itching; This is a spontaneous report from a contactable consumer or other non hcp.   A patient of unspecified age and gender received BNT162b2 (CONMINTARY, Solution for injection, Lot No was not reported, NDC and UPC number was unknown), via an unspecified route of administration on 23Aug2021 as dose number unknown, single for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced itching on 23Aug2021.Outcome of the event was unknown.    The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Received 1st Moderna Vaccine Shot and was very sick first 2 weeks, on 3ed week started getting headaches, blurry vision that now is little to double vision and lost all taste and feeling in hand. They could only do a brain surgery to relieve pressure. They say the original problem is in too dangerous of a spot to remove.  PLEASE HELP !!!! WE NEED HELP !!!
rash the size of his palm of his hand; itchy; warm to the touch; A spontaneous report was received from a consumer concerning a 81-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rash the size of his palm of his hand, itchy, warm to the touch.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 8 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 030M20A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 8 Feb 2021, the patient experienced the event(s) rash the size of his palm of his hand, itchy, warm to the touch.  Treatment for the events were unknown.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), rash the size of his palm of his hand, itchy, warm to the touch was unknown.
pt recv vax 23DEC94 & exp abd cramps & pain;sx persisted for 1wk;pt recv subsequent dose of vax w/no problems;
injection site pain; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 56 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Mar2021 (Lot number: ER2613) at the age of 56 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Low back arthritis" (unspecified if ongoing), notes: Other medical history: Low back arthritis; "SI joint inflammation" (unspecified if ongoing), notes: other medical history: SI joint inflammation; "COVID-19" (unspecified if ongoing), notes: if covid prior vaccination: Yes. There were no concomitant medications. Vaccination history included: Bnt162b2 (Prev dose product: COVID 19,, Prev dose brand: Pfizer,, Prev dose brand unknown: False,, Prev dose lot number: EN6203, Prev dose lot unknown: False, Prev dose number:1,, Prev dose vaccine location: Left arm), administration date: 03Mar2021, when the patient was 56 years old, for COVID-19 Immunization, reaction(s): "Extreme low back pain", "worsening of joint inflammation", "worsening of joint inflammation"; Bnt162b2, administration date: 03Mar2021, when the patient was 56 years old, for COVID-19 immunization, reaction(s): "3 episodes of recurrent injection site pain". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "recovered with sequelae", described as "injection site pain". It was unknown if therapeutic measures were taken as a result of vaccination site pain.  Additional information: The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to COVID vaccine. The patient did not receive any other medications within 2 weeks. Prior to vaccination, the patient was diagnosed with COVID. Since vaccination the patient had not been tested for COVID.  No follow-up attempts are possible. No further information is expected.
Pt called with c/o swelling, pain, heat, soreness. Upon arrival & inspection redness is 3-4" below injection site. It is warm & pt c/o tenderness. V.S. O2 98% T 99.2 temporal 122/68 - 105 - 18. No apparent distress. Discussed with PA-C and Immun. Note - pt has several areas that look like bites and elbow is bruised. Nurse will call pt 07.02.10. Pt to ice, TYLENOL, report changes. On-call info given. Next day 7/2/10 - reports better.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 17-MAY-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (lot# M004116, expiration date 12-OCT-2017; dose, anatomical location and route of administration were not reported). No adverse events were reported and there was no previous temperature excursion. The data logger was involved. Temperature was 21.1 Fahrenheit for 2 hours and 5 minutes, 33.4 Fahrenheit for 6 hours and 5 minutes and 31 Fahrenheit for 3 hours and 30 minutes. This is one of several reports received from the same reporter. Additional information has been requested.
little redness; chills; slight fever; This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (little redness), CHILLS (chills) and PYREXIA (slight fever) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A, 011L20A, 939904 and 014B22A) for COVID-19 prophylaxis.     Concurrent medical conditions included Sleep apnea (on CPAP- diagnosed even before she had the 1st dose of the Moderna Covid-19 vaccine).   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Jul-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced ERYTHEMA (little redness). 03-Feb-2021, the patient experienced CHILLS (chills) and PYREXIA (slight fever). On 04-Feb-2021, ERYTHEMA (little redness), CHILLS (chills) and PYREXIA (slight fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  Patient have received fifth dose of MODERNA COVID-19 VACCINE, BIVALENT in the past, the last one of which was in 11-OCT-2022 (Batch: 053D22A ). and she did not have any serious side effects. No treatment information was reported.
23-month-old child received H1N1 line nasal vaccine licensed for age 24 months and older. Unable to reach parents for report. Left voice mail messages 2-11-10.
Information has been received from a nurse practitioner concerning a 20 year old female who was vaccinated with the third dose of GARDASIL.  The patient experienced severe vertigo followed by severe muscle and joint pain after vaccination.  It was noted that the vertigo began three weeks after the patient received the third dose.  The patient was performed magnetic resonance imaging (MRI) test.  The patient's severe vertigo and severe muscle and joint pain persisted.  The patient sought medical attention and seen by practice.  Additional information has been requested.
High fever in the middle of the night, low grade the next day. Redness at site of injection and soreness.
Arm swelling induration 60mm x 70mm Erythema 50x50 mm deltoid area Supraclavicular Lymph node right side
Age 67, male, went to drive up vaccination station to receive a MODERNA, COVID-19 booster recorded as lot# 011F21A. Had received Moderna COVID-19 vaccinations 1 and 2 without severe reactions. The day after booster vaccination I felt tired and achy. I could not sleep and lost my appetite. I spent days 2-5 post vaccination in bed due to weight loss and fatigue and my body could no regulate its temperature sensation. My temperature fluctuated between 97F and 101.5F. I called my Primary Care Provider who, based on a urinary track procedure two days earlier referred me to a urology nurse who advised I was experiencing a cytokine storm reaction. On day 7 after the vaccination I began to eat minimally. By day 10 post vaccination I was able to begin sleeping and eating more regularly and by day 13 post vaccination I was almost feeling normal again. I fully recovered 15 days after the booster vaccination.
Narrative: Patient received two doses of covid vaccine. Found deceased in home nearing one month after second vaccination. PMH included GAD/depression, ETOH/cannabis abuse, COPD, tobacco dependence, LE PVD, AAA (3.5 cm), colonic polyp, and hyperlipidemia. No further evaluation of death documented.
Complained of rotor cuff pain and shoulder with left upper arm pain. Especially during night, with decreased range of motion ongoing since evening of 07/27/2005. TD given 07/27/2005 in afternoon. Pt came to clinic 08/08/2005 vital signs WNL.
Pt recvd vax & extreme burning/stinging sensation during & p/inject of vax; no further complaints;
Covid-19; Covid-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s).  A 44-year-old female patient received BNT162b2 (BNT162B2), on 01Dec2020 as dose 1, single (Batch/Lot number: unknown), on 01Jan2021 as dose 2, single (Batch/Lot number: unknown) and on 01Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 43 years for covid-19 immunisation. The patient's relevant medical history included: "break-through migraines (Migraine)" (unspecified if ongoing). Concomitant medication(s) included: UBRELVY taken for migraine; AIMOVIG taken for migraine. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "recovered with sequelae" and all described as "Covid-19".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
mom states pt did not want to move rt arm for a short while the day of immun has been fine, active, afebrile until afternoon of 15AUG93 when fell & upon checking pt for injuries found a firm warm nickle-sized nodule about 1 inch above elbow